Achieving net zero – or balancing greenhouse gas (GHG) emissions with their removal – is a key strategic priority for UK ...

Entrepreneurs, startups, charities and social enterprises in Cambridgeshire have been handed the opportunity to access fully ...

SolasCure, a Cambridge biotech developing a novel treatment to transform chronic wound healing, has initiated a new Phase II ...

The Cambridge office of real estate adviser Savills has made eight promotions – the lion’s share of several such moves across ...

AstraZeneca, headquartered in Cambridge, could pay up to $1 billion on a cash and debt-free basis for Belgian company ...

East of England manufacturers have seen a strong start to 2025 according to the latest survey from Make UK and BDO and are ...

Cambridge biotech Maxion Therapeutics has raised $72 million (£58m) in a Series A financing to further grow the business ...

Chancellor Rachel Reeves today unveiled a £2 billion increase to UK Export Finance's Direct Lending capacity for defence, ...

Quarterly Economic Forecast (QEF) has revised down growth expectations for 2025, as firms deal with a raft of rising cost ...

Strategic acquisitions on both sides of the Atlantic – in Cambridge UK and California US – laid the foundations for global ...

We live in uncertain times not only here in the UK, but across the world, and it seems as though what we once understood ...